Laboratoire de Biophotonique et Pharmacologie
UMR CNRS 7213


Partenaires

CNRS
Logo Universite de strasbourg
 

Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Equipe Pharmacologie expérimentale et thérapeutique > Publications

Publication 2006

10 mars 2009

P. BABAL, V. KRISTOVA, A. CERNA, P. JANEGA, O. PECHANOVA, L. DANIHEL & R. ANDRIANTSITOHAINA. Red wine polyphenols prevent endothelial damage induced by CCI4 administration. Physiol. Res. 55, 245-251, 2006

S. LOIBL, J. BRATENGEIER, V. FARINES, G. VON MINCKWITZ, B. SPANKUCH, V. SCHINI-KERTH, F. NEPVEU, K. STREBHARDT & M. KAUFMANN. Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS. Pathol. Res. Pract. 202, 1-7, 2006

C. LOICHOT, L. JESEL, A. TESSE, A. TABERNERO, K. SCHOONJANS, G. ROUL, I. CARPUSCA, J. AUWERX & R. ANDRIANTSITOHAINA. Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions. Am. J. Physiol. 291, H161-H166, 2006

F. MEZIANI, A. TESSE, E. DAVID, M.C. MARTINEZ, R. WANGENSTEEN, F. SCHNEIDER & R. ANDRIANTSITOHAINA. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am. J. Pathol. 169, 1473-1483, 2006

M.H. OAK, J. EL BEDOUI, S.V. FROTA MADEIRA, K. CHALUPSKY & V.B. SCHINI-KERTH. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br. J. Pharmacol. 149, 283-290, 2006

M. SARR, M. CHATAIGNEAU, S. MARTINS, C. SCHOTT, J. EL BEDOUI, M.H. OAK, B. MULLER, T. CHATAIGNEAU & V.B. SCHINI-KERTH. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats : role of NADPH oxidase. Cardiovasc. Res. 71, 794-802, 2006

A. TESSE, M.C. MARTINEZ, F. MEZIANI, B. HUGEL, M.A. PANARO, V. MITOLO, J.M. FREYSSINET & R. ANDRIANTSITOHAINA. Origin and biological significance of shed-membrane microparticles. Endocr. Metab. Immune Disord. Drug Targets 6, 287-294, 2006

F. UN, C. OI, M. PROSSER, N. WANG, B. ZHOU, C. BRONNER & Y. YEN. Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity. Anticancer Res. 26, 2761-2767, 2006